SCHEMBL21709248

SCHEMBL21709248

C#CCOc1cc(C(CN(CC#C)CC#C)OCC#C)c(C#C)cc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21709252 0.90
SCHEMBL21709143 0.89
SCHEMBL21709249 0.85 MAOA (0.31)
SCHEMBL21709245 0.83 P2RX3 (0.31)
SCHEMBL21709276 0.81 P2RX3 (0.33)
SCHEMBL21709250 0.79 MAOA (0.32)
SCHEMBL21709217 0.79
SCHEMBL21709058 0.78 CYP3A4 (0.31)
SCHEMBL21709244 0.76 MAOA (0.32)
SCHEMBL21708884 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020032080-A1 COMPOUND, SALT OF COMPOUND, NEUROMODULATION AGENT, METHOD FOR EVALUATING NEUROMODULATION AGENT, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING SALT OF COMPOUND 学校法人慶應義塾 2020-02-13 WO disclosed